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ABSTRACT OF THE DISSERTATION
Physiological Effects of Vibration in Select Populations
by
Colleen S. Maloney-Hinds
Doctor of Philosophy, Graduate Program in Rehabilitation Science
Loma Linda University, August 2007
Dr. Jerrold Petrofsky, Chairperson

Recently, researchers have demonstrated that Whole Body Vibration results in
significant increases in skin blood flow. No study has determined if there is an optimal
frequency or duration for optimizing this response. In addition, there is no known
mechanism for the increase in skin blood flow. It is hypothesized that nitric oxide (NO)
is responsible for the increase in skin blood flow due to its ability to vasodilate the
smooth muscle in response to shear stress. Therefore, the purpose of this research was to
determine the optimal frequency and duration of vibration and determine if NO is the
mechanism for the vibration-induced skin blood flow increases. In this study three
populations were examined: young adults (age = <45 years, n=53), older adults (age =
>45 years, n=10) and adults with type II diabetes (age = >45 years, n=10). Vibration was
provided by a Power Plate set at either 30 or 50 Hz and skin blood flow was assessed by
a laser Doppler. The role of NO was determined by using venous blood samples, which
were tested for nitric oxide metabolites by a process called chemiluminescence. In
addition, NO production was blocked with L-NAME to see if the skin blood flow
response would be blocked. By the fourth minute 30 and 50 Hz vibration significantly
increased skin blood flow and peak flows were obtained by the fifth minute. Although
there was no significant difference between 30 and 50 Hz, 50 Hz was able to increase
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skin blood flow more rapidly and keep it elevated throughout 15 minutes of recovery. In
the young adults, NO production (544%) and skin blood flow (569%) increased
significantly (p<0.05) after 5 minutes of vibration and then decreased significantly after 5
minutes of recovery. When NO production was blocked, there was a 43% (p<0.05)
decrease in vibration-induced skin blood flow. Skin blood flow and NO production also
increased significantly (p<0.05) in older adults (SBF, 461% NO, 374 %) and adults with
diabetes (SBF, 223% NO, 263). However, skin blood flow in the healthy older adults
increased significantly more than in the adults with diabetes (p=0.003). In conclusion,
vibration is capable of increasing skin blood flow in young adults, older adults and adults
with type II diabetes. It appears that NO is the mechanism for vibration-induced
increases in skin blood flow in the forearm.
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CHAPTER ONE
INTRODUCTION
Recently, a large number of studies examining a method known as Whole Body
Vibration (WBV) have been published. WBV is a technique in which low frequency
vibration is mechanically delivered to the entire body or a specific body part. The
majority of published studies have examined the effect of vibration on muscle (Bosco et
ai, 1999, Roelants et al,. 2006), strength and power (Delecluse et ai, 2003, Roelants et
al, 2004b, Delecluse et ai, 2005), jump height (Rittweger et al, 2000), sprint time
(Delecluse, et al., 2005), metabolism (Rittweger et al, 2002), hormonal release (Bosco
et al, 2000, Cardinale & Lim 2003, Di Loreto et al, 2004, Goto & Takamatsu, 2005),
and body composition (Roelants et al, 2004a). One of the areas that has not been
thoroughly examined is the effect WBV on the peripheral vascular system. A few studies
have examined blood pressure and heart rate (Kerschan-Schindl et al, 2001, Rittwegar et
al, 2000, Yamada et al, 2005). Yet even fewer studies have examined the effect of
WBV on blood flow. A recent study conducted by Lohman et al, (2007) documented
significant increases in skin blood flow due to 3 minutes of 30 Hz vibration on the lower
limb. Many questions arose due to this new finding, yet, there have been no follow-up
studies. One of the questions is whether or not this effect can be replicated. If so, can
similar effects be found on other extremities of the body, such as the arm? Additionally,
if skin blood flow does increase with 30 Hz could a different frequency increase skin
blood flow as well and perhaps yield greater results? Another question is how long do
these effects last.
1

The parameters for vibration-induced increases in skin blood flow only provide part
of the picture. The real mystery is what is causing these increases. Blood flow is
regulated by both extrinsic and intrinsic factors. Extrinsic factors are those that originate
from outside of the area(s) of increased blood flow, such as sympathetic nerves and
humeral factors. The principal role of extrinsic control is to maintain arterial blood
pressure. Intrinsic factors regulate local blood flow to the tissues. Intrinsic factors, such
as local metabolic products, can be derived from endothelial cells as well as vascular
smooth muscle. Local increases in skin blood flow induced by WBV appear to be
independent of exercising skeletal muscle (Lohman et al., 2007). This finding suggests
that local factors are responsible for the increases. Intrinsic factors that promote
vasodilatation include, but are not limited to, nitric oxide (NO), prostacyclin (PGI2),
endothelium-derived hyperpolarization factor (EDHF), and gap junction-mediated
endothelial-smooth muscle hyperpolarization (Lowenstein et al., 1994, McAllister, 1995;
Ledoux et al., 2006).
One of the mechanisms for the release of these metabolites is shear stress. It is
possible that the endothelial cells interpret vibration as shear stress, which in turn
increases the production of NO, prostacyclin, or EDHF. From animal and cell studies
with shear stress, NO appears to play a major role in smooth muscle vasodilatation due to
shear stress (Boo et al., 2002, Uematsu et al., 1995, Nollert et al., 1989, Frangos et al.,
1985). Therefore, it is hypothesized that NO moderates the vibration-induced increases in
skin blood flow.
Regardless of the mechanism increases in skin blood flow would be a benefit to any
population, especially those with poor circulation such as older adults and those with
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diabetes. If shear stress is the cause of the increases in skin blood flow due to vibration,
then all populations may not benefit. Some research indicates that with aging and even
more so with diabetes, the endothelial cells are less responsive to shear stress (Sun et al,
2004; Musicki et al, 2005). Additionally, over time, aging and diabetes can lead to a
decreased synthesis or bioavailability of NO or an inability of the smooth muscle to
respond to NO (Haendeler 2006; Haidara et al, 2006; Gerhard et al, 2000). Therefore, it
is important to examine these populations to see if skin blood flow increases can still be
achieved with vibration, even if shear stress and NO are responsible.
To examine all of these questions a series of three studies were conducted. The first
study examined the effects of 10 minutes of 30 Hz and/or 50 Hz passive vibration to the
forearm to determine if there is an optimal frequency and duration of vibration for
increasing skin blood flow. Additionally skin blood flow was monitored for fifteen
minutes after vibration ceased to determine how long the effects would last. Based on the
optimal parameters obtained from the first study, the second study examined if NO was a
possible mechanism for the vibration-induced increases in skin blood flow. To do this,
two approaches were taken. The first approach attempted to directly measure NO
metabolites in the blood and the second approach attempted to block the increases in skin
blood flow by applying A^-nitro-L-arginine methyl ester (L-NAME), an inhibitor of
nitric oxide synthetase (NOS). The intent of the third study was to determine if skin
blood flow could still be increased in older adults and adults with type II diabetes and if
so, what was the mechanism for these increases.

3

CHAPTER TWO
THE EFFECT OF 30 Hz vs. 50 Hz PASSIVE VIBRATION AND DURATION OF
VIBRATION ON SKIN BLOOD FLOW
Summary
Background: Recently, researchers have demonstrated that Whole Body Vibration
results in significant increases in skin blood flow (SBF). No study has determined if
there is an optimal frequency or duration for optimizing SBF.
Materials and Methods: Two studies were conducted to determine, 1) if there is a
difference in SBF due to passive vibration of the forearm at 30 Hz vs. 50 Hz, 2) if one
frequency is superior, and 3) if there an optimal duration. In the first study, 18 subjects
(mean age 20.3 ± 2.9 years) were randomly placed into a 30 Hz or 50 Hz vibration group,
and in the second, seven subjects (mean age 23.3 ± 3.8 years) participated in both 30 and
50 Hz vibration. Each subject’s arm was passively vibrated for 10 minutes. SBF was
examined during vibration and for 15 minutes of recovery.
Results: Both frequencies produced significant increases in SBF (p<0.05) within the first
four minutes of vibration. Peak SBFs were obtained by the fifth minute. SBF remained
high for minutes 4 through 10 of vibration in the second study. In the first study, SBF
remained high for minutes 4 through 9. During recovery, 30 Hz vibration produced SBFs
below baseline values while 50 Hz remained above baseline. Statistically one frequency
was not superior to the other.
Conclusion: Five minutes of 30 Hz or 50 Hz vibration produced significant increases in
SBF. Clinically, 50 Hz has additional benefits because SBF increased more rapidly and
did not result in vasoconstriction during the recovery period.
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Background
A technique called Whole Body Vibration (WBV) is being used as an alternative
to traditional exercise programs. WBV is a technique in which low frequency vibration
is delivered to the entire body or, in some cases, just a specific part of the body. The idea
is to engage in standard static or dynamic resistance exercise while being vibrated. An
increasing number of studies have been published examining WBV since the initial idea
of using vibration as a training mechanism came about decades ago. The majority of the
studies have examined the effect of vibration on muscle (Bosco et al., 1999, Roelants et
al., 2006), strength and power (Delecluse et al, 2003, Roelants et al, 2004b, Delecluse et
al, 2005), jump height (Rittweger et al, 2000), sprint time (Delecluse, et al, 2005),
metabolism (Rittweger et al, 2002), hormonal release (Bosco et al, 2000, Cardinale &
Lim 2003, Di Loreto et al, 2004, Goto & Takamatsu, 2005), and body composition
(Roelants et al, 2004a). Further, these studies have only examined WBV in healthy and
athletic populations. There are a handful of studies which have looked at the benefits of
WBV on other populations, such as people with multiple sclerosis (Schuhfried et al,
2005), Parkinson’s (Haas et al, 2006) and in the elderly (Bautmans et al, 2005, Bruyere
et al, 2005).
One of the areas regarding WBV that is lacking in research is the effect of the
frequency of WBV on the peripheral vascular system. A few studies have examined
blood pressure and heart rate (Kerschan-Schindl et al, 2001, Rittwegar et al. 2000,
Yamada et al. 2005). Even fewer studies have examined the effect of WBV on skin
blood flow (SBF) (Lohman et al. 2007). These studies revealed that there was an
increase in SBF in the lower extremity, in response to vibration. The exact mechanism
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for the increased SBF due to WBV is unknown. The optimal dose (frequency and
duration) for increased SBF is currently unknown as well. Both Rittweger et al. (2000)
and Kerschan-Schindl et al. (2001) examined blood flow only at 26 Hz. In addition, both
studies employed the use of exercise either with the weight of the body or the addition of
weights. Rittweger et al. (2000) had subjects complete weighted squats until exhaustion
while the whole body was vibrated and Kerschan-Schindl et al. (2001) had subjects
complete a series from standing to squatting within a nine-minute time frame. To date,
only one study has looked at blood flow changes due to passive WBV (Lohman et al.
2007). This study found a significant increase in SBF after 3 minutes of exposure to 30
Hz on the calf. The question arises whether or not greater blood flow increases can be
achieved with a different frequency and in the upper body instead of the lower body.
Additionally, would greater than 3 minutes of exposure to vibration cause greater
increases in SBF?
The purpose of this study was to examine the changes that occur in SBF due to 10
minutes of vibration in the upper body in young healthy subjects. Additionally, two
frequencies, 30Hz and 50Hz, were examined to determine if there were any differences in
SBF response.

6

Materials
Subjects
The first study included 18 healthy volunteers, male (n=l 1) and female (n=7)
(mean age, 20.3 ± 2.9) and the second consisted of 7 healthy volunteers, male (n=3) and
female (n=4) (mean 23.3± 3.8). (Tables 1.1, 1.2) All subjects completed a questionnaire
to assure they were free of cardiovascular and neurological disease, were not chronically
exposed to vibration stimulus (e.g. Jackhammer, train conductor) and that the females
were not pregnant. Subjects taking nitric oxide donors, calcium channel blockers, beta or
alpha-blockers or antagonists were excluded from the study. All subjects had all
procedures explained to them prior to participation and signed an informed consent
document approved by the Loma Linda University, Institutional Review Board.
Vibration
Vibration was delivered by commercial WBV equipment (Power Plate Culver
City, California, USA). The equipment is capable of delivering 30-50 Hz, at high (5-6
mm displacement) or low amplitude (2-3mm displacement). For the purposes of this
study, the machine was set on high amplitude (5-6 mm displacement) which provides a
peak acceleration of 7 G. The frequency was either 50 Hz or 30 Hz for a total of 10
minutes on the dominant arm. Movement in the X, Y and Z directions were verified with
an accelerometer to make sure that weight location or quantity did not alter acceleration.
Weights from 2.3 kg up to 91 kg were placed on the platform and acceleration was
measured. Movement in the X, Y and Z direction remained stable for both 30 Hz (CV:
X= 1.7 %, Y= 1.1% Z= 1.3%) and 50 Hz (CV: X= 1.7%, Y= 1.2% Z= 2.7%). To verify
7

that location did not make a difference, weights were placed in various locations on the
platform and acceleration was measured at 30 Hz (CV: X=1.8%, Y=1.5%, Z= 0.6%), 50
Hz (CV: X= 1.8%, Y=1.2%, Z= .6%).
Blood Flow
All blood flow measurements were taken with a laser Doppler flow meter (Biopac
Systems, Golletta, CA). Before subjects arrived, the Doppler was allowed to warm for 30
minutes to insure reliable measurements. The sensor and amplifier were calibrated just
before the series of experiments. Measurements were taken from the underside of the
forearm, about 2.54 cm distal to the elbow crease and 3.8 cm towards the ulnar from the
center of the inner elbow. Marks were placed on the subjects’ skin with a non-toxic
marker to assure proper realignment.
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Procedures
Subjects were instructed to not have eaten two hours prior to their arrival and to
wear loose comfortable clothing. Subjects rested comfortably for 10 minutes to
acclimatize to the temperature in the room (23-25 °C).

Experiment 1
Subjects were randomized into either the 30 Hz or 50 Hz group by the toss of a
coin. The subjects were then instructed to place their arm onto the vibration platform.
An initial one-minute laser Doppler flow meter measurement was taken on the underside
of the forearm near the elbow. The vibration at either 30 Hz or 50 Hz lasted for 10
minutes. At the end of each minute, SBF was measured with the laser Doppler. Once
vibration ended, additional SBF measurements were made continuously for 15 minutes.

Experiment 2
Subjects in this series participated in both 30 and 50 Hz vibration. Subjects came
on two consecutive days at the same time of day. A coin was tossed to determine which
frequency would be done on which day. The same protocol as in Experiment 1 was
followed.

Data Analysis
Mean baseline SBFs were determined as an average over a one-minute period.
For the remaining SBF measurements, a four-second mean was taken to determine SBF
at each collection point. To account for the variability in the subjects’ baseline blood
flows, all data was converted into a percent of baseline blood flow. An outlier was
removed from the 50 Hz group for statistical analysis because the subject’s SBF readings
9

remained unusually high (550-730 %) for all 15 minutes of recovery. Statistical analysis
was then performed using SPSS 12.0. A Two-Way AVOVA and a Repeated Measures
ANOVA were used to determine differences in blood flow. An independent t-test was
used to insure there was not a significance difference in SBFs between genders. The
level of significance was p < 0.05.
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Results
Experiment 1
No significant difference was found between the SBF responses in the two groups
(30 Hz or 50 Hz) before, during or after vibration (p>0.05). Figure 1.1 appears to show
that the SBF after 50 Hz was greater than that at 30 Hz; however, the variability was so
V

great that there was no significant difference between 30 and 50 Hz. The 30 Hz and 50
Hz groups did differ in the rate at which SBF increased after the onset of vibration. At
the second minute of vibration, the 50 Hz group had a mean SBF of 303%, whereas the
30 Hz group had a mean of 219%. By the third minute of vibration, the 50 Hz group
blood flow was at a mean of 455% of baseline, while the 30 Hz group was at 219%.
There was a significant increase in SBF from baseline in both the 30 and 50 Hz
groups by the fourth minute (30 Hz=225%, 50 Hz=447%, p=0.03)( See Figure 1.1). With
the exception of the seventh minute (p=0.06), SBFs remained significantly high (p<0.05)
up until the ninth minute of vibration. The fifth minute of vibration yielded the greatest
increases in flow with a mean of 360% in the 30 Hz group and a mean of 511% in the 50
Hz group. A second much smaller peak occurred around the eighth minute in the 50 Hz
group and around the ninth minute in the 30 Hz group. Between minute 9 and 10 of
vibration, there was a significant decrease in SBF (90%, p=0.01). By the seventh or
eighth minute of recovery, SBF returned to baseline in the 30 Hz group. By the ninth
minute of recovery in the 30 Hz group skin blood flow dropped below baseline
(mean=78%) and reached its lowest point at 15 minutes after recovery (mean=74%).
SBFs did not return to baseline within the fifteen minutes of recovery in the 50 Hz group.
At minute 15 SBFs remained at a mean of 128%.
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Experiment 2
There was a significant increase in SBF by the fourth minute of vibration in both
treatment conditions (30 Hz=293%, 50 Hz=513%, p=0.002)(See Figure 1.2).

Flows

remained significantly higher throughout vibration treatment and for two minutes after.
In the 50 Hz treatment, SBFs reached 746% at minute 3. SBFs reached their highest
peaks after minute 5 of vibration with both the 30 Hz (517%) and 50 Hz (764%)
treatments (p=0.001). With the 50 Hz treatment, there were two additional peaks at
minute 3 (746%) and minute nine (634%). The 30 Hz treatment had one additional peak
at minute 8 (351%). SBFs remained elevated with the 50 Hz treatment and never reached
baseline (minute 15, 140%). With 30 Hz treatment, SBFs reached baseline shortly at
minute 5 of recovery (99%), and then increased to 184% at minute 6. After minute 9,
(91%), flows continued to drop throughout the remainder of the study. By minute 15
flows were at 65% of baseline.
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Discussion
Both 30 and 50 Hz of passive vibration resulted in significant increases in SBF in
the forearm. These results are similar to those found by Lohman and colleagues (2007),
who documented significant increases in SBF in the calf. In our study, the variability
from subject to subject was so great, that statistically there was no statistically significant
difference between 30 and 50 Hz in the first or second experiment.
It appears that the greatest results are obtained within the first 5 minutes of
vibration. Significant increases in SBF were found by the fourth minute of vibration and
mean peak SBFs were obtained by the fifth minute. On an individual basis, subjects’
SBF peaked between minutes 3 and 5. Similarly, Lohman et al,. (2007) documented
significant increases by the third minute. These results combined indicate that 5 minutes
of vibration will produce the greatest increases in SBF for the majority of subjects. There
are benefits, however, to continuing vibration beyond 5 minutes. SBF remained elevated
above baseline during the entire 10 minutes of vibration. SBFs never reached maximal
again, but additional peaks occurred during vibration. It is possible that the appearance
of additional SBF peaks indicates an adaptive mechanism in the body, which is trying to
achieve homeostasis. This mechanism continues to bring flows back down towards
baseline for a few minutes and then stops. Each peak is smaller as time goes on. Future
studies should be done to determine what mechanism might be responsible for this
occurrence. It is quite possible that nitric oxide (NO) is the mechanism for the increase
in SBF. NO is well known for its capability of causing vasodilatation in response to
shear stress (Berk et al, 1998). A study conducted by Sackner et al, (2005) examined
changes in the dicrotic notch, which is an indirect measurement of NO production, during
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periodic acceleration (2.2m/s2). The authors found NO appears to increase with
acceleration based on the decent of the dicrotic notch. Additionally, this descent appear
to fluctuate during acceleration which the authors pointed out, might indicate that NO is
released in a pulsitile manner (Sackner et al, 2005). If NO is released in this fashion
than it might account for the multiple peaks in SBF that were found in this study. NO
appears to be its own negative feedback system because NO is able to modulate NO
Synthase (Buga 1993). If NO is responsible for the increases in SBF then,
overproduction may lead to NO down regulating further NO production. This might
account for the gradual return to baseline of SBFs during the vibration period and perhaps
why SBF never peaked as high after the fifth minute. Future studies should be done to
determine if NO is responsible for the increase in SBF due to vibration.
Immediately after vibration stopped there was a rapid decrease in SBF. In the 30
Hz group, SBFs were back to baseline between the seventh or ninth minute of recovery.
Not only did SBFs reach baseline but they dropped below baseline indicating
vasoconstriction. With 50 Hz, SBFs decreased rapidly but did not return to baseline
within the monitored 15 minutes of recovery. It might take the body longer to bring
flows down from a peak of 511% or 764% with 50 Hz than 360% or 517% with 30 Hz.
Only one subject (First experiment, 50 Hz) did not follow this trend. Instead, his SBF
remained extremely elevated for the entire duration of the study. This study cannot
account for why this happened. It is possible that this was a very rare or situational
occurrence, since it only happened in this one subject. It cannot be ruled out, however,
that a small percentage of the population might respond to vibration in this manner.
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Overall, the implications of this study are that in young healthy adults with either
30 or 50 Hz 1) SBF in the forearm increases significantly when exposed to passive
vibration. 2) Significant increases in SBF are obtained within five minutes. 3) During
vibration SBF can remain elevated for at least nine minutes. 4) Following exposure to
vibration, blood flow remains elevated for at least seven minutes.
More studies are needed to determine the long-term effects of vibration on SBF.
Vibration may end up being a much better method for increasing blood flow compared to
current methods. Other methods used to increase SBF can lead to serious bums (hot
packs), side effects (medications) or may be too difficult for some populations (exercise).
Almost all the subjects reported enjoying the experience of vibration. Only a few found
in a bit uncomfortable. The fact that SBFs can be increased within such a short time
period and can remain elevated also makes vibration a very feasible, quick and cheap
means of increasing SBF. Future studies should be done to determine if frequencies
other than 30 or 50 Hz produce the same or better results. In this study, only one
amplitude/G-Force (5-6 mm/ 7 G) was measured, future studies should also vary this
parameter to see if greater increases in SBF can be obtained.

15

Conclusion
Both 30 Hz and 50 Hz vibration resulted in significant increases in SBF, which
last for at least 9 minutes. 50 Hz has the advantage of increasing SBF more rapidly and
remaining elevated during recovery, whereas 30 Hz results in SBF dropping below
baseline levels during the recovery period.
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Tables

Table 1.1. General Subject Characteristics for Experiment 1
Age (yrs)
20.3 ±2.9

Height (cm)
168.9 ± 12.2

21

Weight (kg)
88 ± 15.7.6

Table 1.2. General Subject Characteristics for Experiment 2
Age (yrs)
23.3 ±3.8

Height (cm)
167.9 ±9.1

22

Weight (kg)
62.7 ±9.2

Figures

30 vs. 50 Hz Experiment 1

Figure 1.1. This figure illustrates the mean changes in skin blood flow as a percent of
baseline skin blood flow, with standard deviations during baseline, 10 minutes of
vibration and 15 minutes of recovery for both 30 Hz (0)and 50 Hz (□) vibration in the
first experiment.
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30 vs. 50 Hz Experiment 2

Figure 1.2. This figure illustrates the mean changes in skin blood flow as a percent of
baseline skin blood flow, with standard deviations during baseline, 10 minutes of
vibration and 15 minutes of recovery in the second experiment. Each subject was
exposed to both 30 Hz (0) and 50 Hz (□) vibration.
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CHAPTER THREE
ROLE OF VIBRATION-INDUCED NITRIC OXIDE IN INCREASING SKIN
BLOOD FLOW OF THE FOREARM OF HEALTHY YOUNG ADULTS

Abstract
Purpose: Recent studies document increases in skin blood flow due to a new exercise
technique called Whole Body Vibration. Currently, no known mechanism explains these
increases in skin blood flow. It is hypothesized that vibration-induced increases in skin
blood flow are due to local increases in NO synthesis, since it is known that endothelialderived NO is released in response to flow shear stress in blood vessels. Methods: In
the present investigation, we measured NO metabolites as well as blocked NO production
with L-NAME while measuring changes in skin blood flow before, immediately after,
and 5 minutes after externally applied passive vibration (50 Hz) to the forearm of human
volunteers (n=28). Results: We measured skin blood flow before, during, and shortly
after the application of forearm vibration as well as blood levels of NO drawn from the
brachial vein. We found that vibration significantly (p<0.05) and rapidly increased skin
blood flow (569%), which decreased to 192% within minutes after vibration ceased. In
addition, measured increases in NO production, expressed as NO (|iimole/ltr),(flux),
occurred immediately after vibration (544%) and paralleled changes in blood flow.
lontophoretically applied L-NAME, a NO synthesis inhibitor, significantly, but not
completely, decreased vibration-induced skin blood flow. L-NAME significantly
(p<0.05) blocked 43% of the skin blood flow increase caused by vibration. Conclusion:
We conclude that NO plays a significant role in the increases in skin blood flow due to
vibration.
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Introduction
Exercise equipment that delivers low frequency vibration to the entire body has
become a recent health and fitness trend. In support of the use of this equipment
researchers have reported that Whole Body Vibration (WBV) can enhance traditional
resistance training techniques. Commercial devices now capitalize on this trend in fitness
training. Utilizing these devices, research studies have investigated the effect of vibration
on muscle (Bosco et ai, 1999, Roelants et ai, 2006), strength and power (Delecluse et al.
2003, Roelants et ai, 2004b, Delecluse et al., 2005), jump height (Rittweger et al., 2000),
sprint time (Delecluse, et al., 2005), metabolism (Rittweger et al., 2002), hormone
release (Bosco et al., 2000; Cardinale & Lim, 2003; Di Loreto et al., 2004; Goto &
Takamatsu, 2005), and body composition (Roelants et al., 2004a).
The majority of studies have examined the effects of WBV on skeletal muscle,
and only a relatively few have examined the effects on components of the cardiovascular
system. These studies measured the effects on blood pressure and heart rate (KerschanSchindl et ai, 2001, Rittwegar et al, 2000, Yamada et al, 2005). To the best of our
knowledge, only a few studies have examined the effect of WBV on blood flow. These
studies reveal that there is an increase in blood flow in response to vibration (Rittweger et
al, 2000; Kerschan-Schindl et al, 2001; Lohman et al, 2001 \ Maloney-Hinds et al.,
2007). Although these studies revealed statistically significant increases in blood flow, at
this time, the mechanism underlying this effect is unknown.
Blood flow is regulated by both extrinsic and intrinsic factors. Extrinsic factors
are those that originate from outside of the area(s) of increased blood flow, such as
sympathetic nerves and humeral factors. The principal role of extrinsic control is to
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maintain arterial blood pressure. Intrinsic factors regulate local blood flow to the tissues.
Intrinsic factors, such as local metabolic products, can be derived from endothelial cells,
as well as vascular smooth muscle. Local increases in skin blood flow induced by WBV
appear to be independent of exercising skeletal muscle (Lohman et ai, 2007). This
finding suggests that local metabolic factors are responsible for the increases. Intrinsic
factors that promote vasodilatation include, but are not limited to, nitric oxide (NO),
prostacyclin (PGL), endothelium-derived hyperpolarization factor (EDHF), and gap
junction-mediated endothelial-smooth muscle hyperpolarization (Lowenstein et ai, 1994,
McAllister, 1995).
Endothelium-produced NO, released in response to shear stress or due to local
changes in p02and pH (Boo et al, 2002, Uematsu et al., 1995, Nollert et ai, 1989,
Frangos et al., 1985), is a likely intrinsic mechanism for increasing local blood flow. It is
possible that the endothelial cells interpret vibration as shear stress, which causes the
production of NO, which, in turn, relaxes vascular smooth muscle and increases blood
flow.
To test the hypothesis that NO produced locally in response to applied vibration
increases skin blood flow, we measured both skin blood flow and venous NO levels from
the forearms of normal human volunteers before, during, and shortly after applied
vibration. In addition, we tested the effects of locally iontophoresed L-NAME, an
inhibitor of nitric oxide synthetase (NOS), on blood flow.
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Methods
Subjects
Our studies were conducted with three groups of healthy, human volunteers:
group A consisted of 11 (23.3 ±3.6 yrs) healthy male (n=4) and female (n=7) subjects;
group B consisted of 7 (24.7 ± 0.8 yrs), healthy male (n=3) and female (n=4) subjects;
and group C consisted of 10 (32.3 ± 11.5 yrs) healthy male (n=4) and females (n=6)
subjects. See Table 2.1 for subject characteristics. All were free from cardiovascular and
neurological disease. Subjects were administered a questionnaire and were excluded if
they were chronically exposed to vibration stimulus (e.g. jackhammer), taking any
medications that could influence nitric oxide, or if they were pregnant. The Institutional
Review Board of Loma Linda University and Azusa Pacific University approved all
protocols. All experimental procedures and protocols were explained to each subject,
who then signed an informed consent document.
Vibration
Vibration was delivered by commercial WBV equipment (Power Plate®, North
America, LLC, Culver City, California, USA). The equipment is capable of delivering
30 and 50 Hz vertical displacements at high (5-6 mm displacement) or low amplitude (23mm displacement). In all experiments, subjects were exposed to 50 Hz, high amplitude
(5-6 mm, approximately 7g) vibration for a total of 5 minutes. Vibration equipment
parameters were verified in a previous study (Maloney-Hinds et al. 2007).
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Blood Flow
Relative blood flow was measured with a laser Doppler flow meter (Biopac
Systems, Goleta, CA) and converted with a MP100, 16 bit A/D converter at 2000
samples/second. The data was analyzed with Acknowledge 3.9.1, and results were
reported in units of flux. The flow meter was warmed up for 30 minutes to insure reliable
measurements prior to being used. The flow sensor and amplifier were calibrated
immediately before each series of experiments. Measurements for the first experiment
(group A) were taken from the medial aspect (underside) of the forearm, about 1 inch
distal to the elbow crease and 1.5 inches towards the ulnar from the center of the inner
elbow. Measurements for the second (group B) and third (group C) experiments were
taken at the site of iontophoresis, as explained in the next section. Previous experiments
in our lab indicated that skin blood flow was greatest at the points where the arm made
contact with the vibration platform (underside) and the areas directly opposed (top of
arm). Since the amount of tissue in the arm varies from subject to subject, the underside
of the forearm was chosen so that the true effect of direct vibration could be measured
and not how well the vibration and its response traveled through the tissue. Marks were
placed on the subjects’ skin with a non-toxic marker to assure proper realignment.

Iontophoresis
L-NAME (A^-nitro-L-arginine methyl ester; Sigma Chemical Co. St. Louis, MO)
was applied iontophoretically (IOMED Phoresor II Auto) onto the forearm approximately
1 inch distal from the elbow and 1 inch medially from the center of the elbow joint. The
area of skin was oval shaped and 2 inches long by 1 inch wide. This area of the forearm
was chosen since it makes the best contact with the vibration platform. L-NAME (50
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mmoles) was applied with a positive electrode for either 3 minutes at 0.3 mA (Group B)
or 5 minutes at 0.5 mA (Group C) Distally and adjacent to the L-NAME site was a
control patch of skin which received either no treatment (Group B) or a saline treatment
(Group C). Two iontophoretic units were used so that the L-NAME and saline could be
applied to adjacent areas of skin at the same time.

Venous Blood Collection
Venous blood samples were drawn from the brachial vein of each subject’s
dominant/treatment arm by a licensed phlebotomist. A total of three samples (3 ml each)
were taken: before vibration; immediately after vibration; and 5 minutes after vibration.
Immediately after each blood draw, a nitrite preservation solution was added to the blood
sample at a ratio of 1:4 (v/v; 1 ml preservation solution to 4 ml whole blood) (Pelletier et.
al., 2006). The preservation solution consisted of 0.8 M ferricyanide, 0.1 M Nethylmaleimide, and 500 pi (10% of final volume) of Nonidet P-40. Whole blood
samples were kept on wet ice at 4° C for no longer than 3 hours and then stored frozen at
-80° C until processed (Pelletier et. al., 2006).

Nitric Oxide
Nitric Oxide (NO) concentrations were determined by measuring total nitrite in
the blood. After production, endothelial-derived NO enters the blood or diffuses into the
smooth muscle. NO that is not immediately utilized or bound can be oxidized to form
nitrite. Hence, greater activation of eNOS leads to greater levels of both NO and nitrite
(Nagababu et al. 2007; Lauer et al. 2001; Gladwin et al. 2000; Kelm et al. 1999). For the
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purposes of the present study, it will be assumed that measured nitrite translated into
increased NO concentrations due to increased production via nitric oxide synthase.
Blood samples were thawed and then deproteinated with methanol (1:1). The
samples were then centrifuged at 15,000 g for 3 minutes at room temperature and the
supernatant fraction was transferred to a clean tube. The supernatant fraction was
centrifuged again for 3 minutes to remove any residual precipitate. Aliquots (200 pi)
were injected into a tri-iodide solution, which consist of 400mg of potassium iodide, 260
mg of iodine, 8ml of Millipore water, and 28 ml of 100% acetic acid. This solution
reduces nitrite, iron-nitrosylheme, and S-nitrosothiol into gaseous NO, which was then
measured with an ozone-based chemiluminescence detector (Model 280i Sievers, NO
analyzer, Boulder, CO). Although this method measures nitrite in the blood, the ultimate
source of the nitrite was from nitric oxide.
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Procedures
Three series of experiments were conducted to determine if NO plays a role in
skin blood flow increases due to vibration. The first experiment measured NO in the
blood and correlated it with skin blood flow. To verify that NO was responsible for these
increases the second experiment attempted to block NO with L-NAME to block the
increases in skin blood flow due to vibration. Since L-NAME only blocked a portion of
the skin blood flow response the third experiment varied the parameters of L-NAME
iontophoresis and examined recovery.
Upon arrival, all subjects signed an informed consent document and were asked to
remain seated and relaxed for a total of 10 minutes so that they could acclimatize to the
environment (220-24° C).
Series 1: Measured NO and Skin Blood Flow
Once acclimatized, subjects had their first blood sample taken and skin blood flow
measured. Subjects then sat in front of the vibration platform with their dominant
foreann and hand placed palm down on the platform. Five minutes of 50 Hz high
frequency vibration was applied to the arm. Immediately after, another blood sample and
skin blood flow measurements were taken. The subjects then remained seated for 5
minutes of recovery after which one more blood sample and skin blood flow
measurement was taken.
Series 2: eNOS Inhibition and Skin Blood Flow
After 10 minutes, marks with a non-toxic marker were made on the forearm to
insure proper alignment of repeated skin blood flow measurements. An initial baseline
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skin blood flow measurement was then taken at the two sites (L-NAME and Control) on
the forearm. L-NAME was then iontophoresed for a total of 3 minutes at 0.3 mA.
Immediately after, blood flow measurements were taken again to detennine any effect
from the iontophoresis. The subjects were then exposed to 5 minutes of 50 Hz high
frequency vibration. As soon as vibration ceased, skin blood flow measurements were
repeated at the two sites.
Series 3: eNOS Inhibition, Skin Blood Flow and Recovery
After 10 minutes, two marks were made on the dominant forearm to insure proper
realignment of blood flow measurements. Then baseline skin blood flow measurements
(saline site and L-NAME site) were taken. Immediately after, L-NAME and saline were
iontophoreised for 5 minutes at 0.5mA. Another skin blood flow measurement was taken
from each site right before beginning the 5 minutes of 50 Hz high frequency vibration.
Immediately after vibration ended, another set of skin blood flow measurements were
taken. The subjects then rested for 5 minutes and a last set of skin blood flow
measurements were taken.
Analysis
NO concentrations were measured as venous nitrite concentration (see Methods)
in collected specimens of venous blood and expressed in units of pmoles/ltr. Blood flow
in the skin was detennined by laser Doppler (see Methods) and expressed in relative units
of flux rather than absolute units of Itr/sec. The rate of NO production is equal to the
product of the blood nitrite concentration and rate of blood flow, and is expressed in
relative units of (pmole/ltr)*(flux) rather than in units of pmole/sec. Thus, to determine
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the rate of NO production, a modified version of Pick’s Principle was used (Boron and
Boulpaep, 2003; see equation below):
R= C • F
where, C= nitrite concentration of blood (moles/ltr)
F = relative blood flow (Itr/sec) or = flux
R = rate of production (moles/sec) or (moles/ltr)(flux)
Repeated Measures ANOVA were used to determine mean differences in skin
blood flows, nitrite concentration, and rate of NO production (pmole/ltr)#(flux) at
different stages of each experiment. In the third study, an interaction was found so a
cross-sectional analysis was performed to look at each skin patch for each condition, as
well as over time period.
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Results

Series 1: Measured NO and Skin Blood Flow
To test the hypothesis that vibration-induced blood flow is mediated by increased
NO production, we measured both skin blood flow and NO concentration from blood
samples before, immediately after 5 minutes of vibration, and after 5 minutes of recovery
in Series 1. Skin blood flow increased significantly (p = 0.002) by 579% immediately
after vibration and then decreased significantly (p = 0.007) to 157% of baseline after 5
minutes of recovery (Fig. 2.1). The rate of NO production, as expressed as NO
(pmole/ltr)*(flux), associated closely with the concomitant vibration-induced changes in
skin blood flow, increasing significantly (p = 0.03) by 544% immediately after 5 minutes
of vibration and then decreasing significantly (p = 0.047) to 122% of baseline 5 minutes
later (Fig. 2.1; Table 2.2).
Series 2: eNOS Inhibition and Skin Blood Flow
Results indicated that vibration of the forearm produced concomitant increases in
skin blood flow and NO production. These results are consistent with the hypothesis that
the increased skin blood flow observed in response to applied vibration is caused by a
vibration-induced increase in the production of NO. If true, then inhibiting nitric oxide
synthetase in the skin should block vibration-induced increases in skin blood flow. To
test this prediction of our hypothesis, an attempt to inhibit NO production by
iontophoretically applying the nitric oxide synthetase inhibitor, L-NAME, to a defined
area of the skin on the forearm while measuring the effect of vibration on skin blood flow
was made. We applied L-NAME for 3 minutes at 0.3 mA and we measured skin blood
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flow before, immediately after iontophoresis, and then 5 minutes later following 5
minutes of vibration. No significant differences in skin blood flow were observed
between the control area of skin and the L-NAME area at baseline or after iontophoresis
(Fig. 2.2; Table 2.3). After 5 minutes of vibration, skin blood flow in the control area
increased 695% (p 0.01), but only 366% (p = 0.02) in the L-NAME area. Thus, there was
a 47% difference (p = 0.01) between the skin blood flow in the control areas and the LNAME areas of skin.
To determine whether L-NAME directly affects skin blood flow in the absence of
vibration, we monitored skin blood flow continuously for 10 minutes immediately after
iontophoresis of L-NAME for 3 minutes at 0.3 mA on three subjects. Skin blood flow
remained constant for the entire 10-minute period (29 ± 2.7 flux).
Series 3: eNOS Inhibition, Skin Blood Flow and Recovery
To detennine if the increased vibration-induced skin blood flow in the L-NAME
treated area was due to incomplete inhibition of endogenous nitric oxide synthetase
activity, the duration of iontophoresis was increased from 3 to 5 minutes and the current
was increased in intensity from 0.3 to 0.5 mA. Furthermore, to measure the effect of LNAME on the extent of recovery 5 minutes after the cessation of vibration, we measured
skin blood flow before and after iontophoresis, immediately after 5 minutes of vibration,
and 5 minutes after cessation of vibration. No significant differences were observed in
skin blood flow between the saline and L-NAME areas of skin at baseline or after
iontophoresis (Fig. 3; Table 4). Consistent with the previous experimental findings, there
was a 531% increase (p = 0.012) in skin blood flow to the saline area immediately after 5
minutes of vibration and a 325% increase (p = 0.028) to the L-NAME area of skin,
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yielding a 39% difference (p = 0.005) between the saline/control patch and the L-NAME
patch of skin immediately after vibration. This difference in skin blood flow between the
saline and L-NAME treated areas persisted following 5 minutes of recovery where there
was a 40% difference (p = 0.02) in skin blood flow between the saline and L-NAME
treated areas. Following 5 minutes of recovery the skin blood flows to the saline areas
and L-NAME treated areas decreased significantly [330% (p = 0.03) and 191% (p =
0.02), respectively].
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Discussion
The principal objective of the present study was to determine the mechanism
underlying vibration-induced increases in skin blood flow. An increase in NO production
is a logical mechanistic choice due to the ability of NO to dilate vessels in response to
shear stress (Moncada et al. 1991). Toward that end, we hypothesized that externally
applied vibration stimulates an increase in vascular NO synthesis, which, in turn, induces
the adjacent vascular smooth muscle to dilate, thereby increasing blood flow. This study
showed that vibration-induced increases in skin blood flow are concomitant with
increases in the rate of NO production and to the same extent. Furthermore, 5 minutes
after cessation of vibration, both blood flow and NO production decrease to the same
extent. These findings establish that immediately after the applied vibration, as well as 5
minutes later, tandem vibration-induced changes in skin blood flow and rate of NO
production occur and that these changes are consistent with the predictions of our
governing hypothesis.

To determine if the increase in NO production is mechanistically upstream to the
vibration-induced skin blood flow, the ability of iontophoretically applied L-NAME, a
nitric oxide synthase inhibitor, to inhibit vibration-induced skin blood flow was tested.
Our findings from two experiments indicated that L-NAME significantly inhibits
vibration-induced skin blood flow in L-NAME treated areas of skin. These findings
suggest that increased NO production is upstream of vibration-induced skin blood flow.
These findings are consistent with the predictions made by our hypothesis.

Thus, it appears that NO is regulating the increases in skin blood flow in response
to vibration. These findings agree with Sackner et al. (2005) who investigated changes in
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the dicrotic notch of individuals during periodic acceleration (2.2m/s2). The descent of
the dicrotic notch suggested that NO production from vascular endothelial cells increased
due to the acceleration. Our study went a step further by directly measuring blood nitrite,
a stable NO metabolite in the blood. Although this method supports the conclusion that
NO is responsible for vibration-induced increases in skin blood flow, one methodological
limitation is that we did not directly measure NO. NO is short lived in the blood (Liu et
al, 1998) making direct measurement difficult. Instead, increases in blood nitrite and
nitrate, which are derivatives of NO, are commonly measured to determine the activity of
NOS and, therefore, NO production. Since nitrate can also be created from non-NOS
sources, nitrite is a better indicator (Nagababu et al, 2007). For these reasons, nitrite was
measured in the present study. For the purposes of our calculations, we assumed that
increased levels of nitrite represented increased eNOS activity and, therefore, increased
NO production. Our observed effects of L-NAME treatment support our assumption.
Present results indicated that 5 minutes of 50 Hz vibration applied to the forearm
significantly increases skin blood flow (569%, N=28). These results are qualitatively
similar, but of greater magnitude, than results in a recent study (Lohman et al, 2007) that
reported a 250% increase in skin blood flow after vibration treatment. Among the
possible explanations for the differences in reported increased skin blood flow are the
duration of vibration or the choice of frequency. Lohman et al. (2007) used 3 minutes of
30 Hz vibration, while the present study used 5 minutes of 50 Hz vibration. A previous
study has shown, however, that 50 Hz elicits a higher magnitude response in blood flow
from the forearm than 30 Hz for the same duration of exposure (Maloney-Hinds et al,
2007). Additionally, differences in magnitude of the blood flow response may be due to
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the body part monitored and/or whether it was vibrated in a passive or active state. In the
present study, the dominant, resting forearm was selected, while in Lohman et al. (2007)
the standing lower leg was used. The forearm was selected in the present study because
of the relative ease in collecting venous blood from the arm compared to the leg. In both
studies, elevated skin blood flow persists, albeit at a lower level, for at least 5 minutes
after the vibration stops.
Two of the series measured skin blood flow 5 minutes after cessation of vibration
to measure the extent of recovery from vibration. Significant differences were observed
in skin blood flow 5 minutes after vibration ended (group 1 mean = 87± 33 versus group
3 mean = 205 ± 143). The two groups were similar except for age and body mass index
(BMI). When age was used as a covariate, no significant differences due to age were
found (p=0.19). Future studies should be conducted to determine whether the variation in
blood flow during recovery was due to vascular effects resulting from differences in
BMI.
We utilized L-NAME to block locally synthesized NO to confirm that NO was
causing the increase in skin blood flow. Our results indicated that L-NAME significantly
reduced vibration-induced skin blood flow by almost a half. Several possible reasons
may explain why vibration-induced blood flow response was not completely blocked by
L-NAME. The duration or voltage of the iontophoresis or the amount of iontophoresed
L-NAME may have been insufficient. The initial choice of 0.3 mA for was chosen based
on a previous study conducted in our lab in which L-NAME was used to block the skin
blood flow response to electrical stimulation (Petrofsky et al. 2007). The only other
study found in which L-NAME was applied with iontophoresis was Medow et al. (2005)
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which applied L-NAME for a total of 20 minutes at 1 OOpA. In our study, L-NAME was
only applied for a total of 3 minutes in the second experiment and 5 minutes in the third,
so a longer treatment might have completely blocked vibration-induced blood flow. A
study by Adams and colleagues (2003) delivered L-NAME by catheter to pigs and
examined the response of other cardiovascular parameters, such as blood pressure, due to
acceleration. They also found that L-NAME was not able to entirely block observed
responses. They speculated that this could have been due to a dose response or another
mechanism. Although the entire response was not completely blocked in this study, there
was sufficient inhibition to conclude that vibration stimulated significant NO production,
which regulates a large component of the vibration-induced skin blood flow. Further
studies are needed to investigate the extent to which NO production mediates the
vibration-induced skin blood flow.
Another reason why L-NAME may not have completely blocked the response is
that additional endogenous vascular mediators may be involved. These may include
prostacyclin or endothelium-derived hyperpolarization factor (Lowenstein et al., 1994,
McAllister 1995). Prostacyclin is a likely candidate since many studies have shown it
causes vasodilatation of the smooth muscle in response to shear stress (Ballermann et al.
1998; Frangos et al. 1988) Adams et al. (2005) found significant increases in
prostacyclin due to periodic acceleration (±0.4x g) for 60 minutes in piglets. Osanai et
al. (2000) also determined that shear stress releases prostacyclin, but interestingly
enough, these two metabolites appear to cross talk and when NO is released, it inhibits
prostacyclin to some extent. Therefore, prostacyclin may play a role in vibration-induced
skin blood flow increases, but it is unlikely to be the major contributor. Future studies
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should investigate the role that prostacyclin plays in skin blood flow increases due to
vibration in humans.
In conclusion, the present findings indicate that NO plays a significant role in
increasing skin blood flow due to externally applied vibration. As a natural process of
aging, or disease (e.g. diabetes), vascular NO production decreases (Petrofsky et al, 2005;
Haendeler 2006; Haidara, 2006). These decreases can lead to an increased risk of high
blood pressure, blood clots, and endothelial damage, which can lead to atherosclerosis
(Harrison et al., 2006). Methods that elevate NO levels in certain patient groups may be
useful for slowing or reversing the damage done by low NO levels. Both exercise and
medication have been used for this purpose (Franzoni et al., 2004). Medication suffers
from the risk of side effects, and increased exercise depends upon physical factors that
decrease with age and morbidity. Externally applied vibration may increase NO levels
safely. Future studies should be done to examine the effect of vibration on both older
adults as well as those with diabetes to determine if it could be an appropriate treatment.
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Tables

Table 2.1. General subject characteristics for Experiment 1, 2 and 3 with SD

Experiment

Age (yrs)

Weight (kg)

Height (cm)

BMI

N

1

23.3 ±3.6

64 ±11.8

168.7 ± 5.8

22.5 ±3.8

11

2

24.7 ±0.8

65.8 ±17.9

175.3 ±14.1

22.37 ±3.2

7

3

32.2 ± 11.5

75.6 ± 20.4

171.7± 11.4 25.3±4.4

48

10

Table 2.2. Skin blood flow, NO concentration, and NO production. Means and SD for
skin blood flow, NO concentration, and NO production for baseline, vibration, and after 5
minutes of recovery.

Time

Skin Blood Flow
(Flux)

NO
(NO)

NO
(pmole/ltr)*(flux)

Baseline

56 ±30

0.15 ±0.08

9±6

Vibration

324± 187

0.14 ±0.06

49 ±42

Recovery

88 ±33

0.13 ±0.05

11 ±5

49

Table 2.3. Effect of L-NAME on vibration-induced skin blood flow increases. Mean
skin blood flow from the L-NAME and control patch of skin before iontophoresis, after
iontophoresis (0.3 mA current for 3 minutes) and after 5 minutes of vibration.

Treatment

Baseline

Post Iontophoresis

Vibration.

L-NAME

28 ±8

28 ±7

101 ±63

Control

22 ±8

38 ±9

264±166

50

Table 2.4. Effect of greater duration and current of L-NAME on skin blood flow.
Changes in means and SD for skin blood flow at baseline (A), after iontophoresis (B) of
either L-NAME or saline (0.5 mA for 5 minutes), immediately after 5 minutes of 50 Hz
vibration (C) and 5 minutes after recovery (D).

Treatment
A

Skin Blood Flow
B
C

D

Saline

65 ±23

62 ±28

331 ±279

205 ± 143

L-NAME

52 ± 17

51 ± 18

166±141

98 ±47

51

Figures

Skin blood flow, NO concentration and NO production

Figure 2.1. Mean changes in skin blood flow (O), shown on the primary vertical axis,
NO production (A), shown on the secondary vertical axis, and NO concentration (□),
shown in the insert are depicted for Baseline (B), after 5 minutes of 50 Hz vibration (V)
and after 5 minutes of recovery (R).
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Vibration, L-NAME and its effect on skin blood flow

Figure 2.2. Shows changes in mean skin blood flow (flux) and SE where L-NAME (0)
was applied and in the control area (□) at baseline, immedielty after 3 minutes of 0.3 mA
iontophoresis of L-NAME and immedielty after 5 minutes of 50 Hz vibration.
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Vibration, L-NAME and its effect on skin blood flow and recovery time
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Vibration

Recovery

Figure 2.3. Illustrates mean skin blood flow in the L-NAME (0) and Saline (□)
treatement area at baseline, immediately after 5 minutes of 0.5 mA iontophoresis, after 5
minutes of vibration, and after 5 minutes of recovery.
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CHAPTER FOUR
THE ROLE OF NITRIC OXIDE IN MEDIATING VIBRATION-INDUCED SKIN
BLOOD FLOW INCREASES IN OLDER ADULTS AND ADULTS WITH DIABETES

Abstract
A recent study documented increases in skin blood flow and Nitric Oxide (NO)
in young healthy adults due to Whole Body Vibration. Methods that increase blood
flow and NO may aid in the reduction of cardiovascular disease associated with aging
and diabetes. Therefore, the purpose of this study was to determine if skin blood flow
and NO could be increased in the forearms of older adults with Type II diabetes and
healthy age matched controls with 5 minutes of vibration at a frequency of 50 Hz. Skin
blood flow and NO were measured before, immediately after vibration and 5 minutes
after vibration ceased. Vibration significantly increased (p=0.0001) skin blood flow for
both groups, however, those with diabetes (223%) had a significantly lower (p=0.003)
skin blood flow response to vibration compared to the healthy older adults (461%). NO
production, expressed as NO (pmole/ltr) • (flux), increased significantly (p=0.001) in
both groups after vibration (healthy 374%, diabetic 236%) and remained significantly
elevated (healthy 258%, diabetic 177%) for at least five minutes. These findings
indicate that diabetes leads to a decreased capacity of NO to communicate with the
smooth muscle, however, vibration still significantly increased NO and skin blood flow
in both groups. Future studies should investigate the possibility of vibration as a
therapeutic tool.
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Introduction
Nitric oxide (NO) is a messenger in the cardiovascular system as well as in the
nervous system. In the cardiovascular system, NO dilates blood vessels, fights
pathogens, and inhibits platelet adhesion (Lowenstein et ai, 1994; Stamler et al, 1992;
Moncada et al,. 1991). Therefore, a decrease in the production or ability to utilize NO
would promote a hypertensive, thrombotic environment. Over time, aging and diabetes
can lead to a decreased bioavailability of NO or inability of the smooth muscle to respond
to NO (Haendeler, 2006; Haidara et ai, 2006; Petrofsky and Lee, 2005, Gerhard et al,
2000). This can lead to or be caused by damage to the endothelial cells, which
contributes to cardiovascular disease (Harrison et al, 2006). To halt or reduce this
progression, efforts should be made to increase NO production. Research has shown this
can be accomplished through the use of an NO donor or with exercise (Franzoni et al,
2004). Medication, however, has side effects, interacts with other medications, and can
be expensive. Exercise, a healthier alternative, can be difficult for those who are older,
overweight, or have complications due to diabetes. It would be advantageous to many, if
a technique which is safer, simpler, and quicker were available.
Recently, Maloney-Hinds and colleagues (2007) found that 5 minutes of 50 Hz
vibration significantly increased NO levels and skin blood flow levels in young healthy
adults. Sackner et al, (2005) also found increases in indirectly measured NO in response
to period acceleration. Vibration would be a much simpler, safer, cost and time efficient
way to increase NO. The only possible drawback is that the most likely cause of the NO
increases is shear stress. Some research indicates that with aging and even more so with
diabetes, the endothelial cells are less responsive to shear stress (Sun et al, 2004;
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Musicki et ai, 2005). This indicates that vibration might not be capable of increasing
NO in these populations.
Therefore, the purpose of this study was to determine if vibration can cause
increases in NO and skin blood flow in healthy older adults and adults with type II
diabetes. Additionally, we hypothesized that the diabetic group would have less of a
response than the healthy group.
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Materials
Subjects
Ten male (n=6) and female (n=4) older adult subjects (age, 55 ± 7.7 yrs),
and 10 male (n=6) and female (n=4) subjects with type II diabetes (age, 56.9 ± 7.5
yrs) took part in this study. See Table 3.1 for subject characteristics. All were
free of cardiovascular and neurological disease, with the exception of being
diabetic. Subjects were administered a questionnaire and were excluded if they
were chronically exposed to a vibration stimulus (e.g. Jackhammer) or if females
were pregnant. Subjects were also questioned about their use of nitric oxide
donors, calcium channel blockers, beta or alpha-blockers or antagonists. To
determine glucose control over the past three months, a hemoglobin A1C test was
done on each subject with diabetes using blood from the first venous draw (mean
hemoglobin A1C= 6.6% ± 1.1%, Min 5%-Max 8.2 %). The Institutional Review
Board of Loma Linda University approved all protocols. All experimental
procedures and protocols were explained to each subject and each signed an
informed consent document prior to participation.

Vibration
Vibration was delivered by a commercial piece of equipment designed by
Power Plate ® (North America, LLC, Culver City, California, USA). The
equipment is capable of delivering 30-50 Hz, at high (5-6 mm displacement) or
low amplitude (2-3 mm displacement). In all experiments, subjects were exposed
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to 50 Hz, high amplitude (5-6 mm, approximately 7g) vibration for a total of 5
minutes.

Blood Flow
Relative blood flow was measured with a laser Doppler flow meter
(Biopac Systems, Goleta, CA) and converted with a MP100, 16 bit A/D converter,
at 2000 samples/second. The data was analyzed with Acknowledge 3.9.1 and
results were reported in units of flux. The flow meter was warmed up for 30
minutes prior to being used to insure reliable measurements. The flow sensor and
amplifier were calibrated immediately before each series of experiments.
Measurements were taken from the underside of the forearm, about 1 inch distal
to the elbow crease and 1.5 inches towards the ulnar from the center of the inner
elbow.

Venous Blood Collection
Venous blood samples were drawn from the brachial vein of each subject’s
dominant/treatment arm by a licensed phlebotomist. A total of three samples (3 ml each)
were taken: before vibration; immediately after vibration; and 5 minutes after vibration.
Immediately after each blood draw, a nitrite preservation solution was added to the blood
sample at a ratio of 1:4 (v/v; 1 ml preservation solution to 4 ml whole blood) (Pelletier et.
al., 2006). The preservation solution consisted of 0.8 M ferricyanide, 0.1 M Nethylmaleimide, and 500 pi (10% of final volume) of Nonidet P-40, Whole blood
samples were kept on wet ice at 4° C for no longer than 3 hours and then stored frozen at
-80° C until processed (Pelletier et. al., 2006).

59

Nitric Oxide
Nitric Oxide (NO) concentrations were determined by measuring total nitrite in
the blood. After production, endothelial-derived NO enters the blood or diffuses into the
smooth muscle. NO that is not immediately utilized or bound can be oxidized to form
nitrite. Hence, greater activation of eNOS leads to greater levels of both NO and nitrite.
For the purposes of the present study, it will be assumed that measured nitrite translated
into increased NO concentrations due to increased production via nitric oxide synthase.
Blood samples were thawed and then deproteinated with methanol (1:1). The
samples were then centrifuged at 15,000 g for 3 minutes at room temperature and the
supernatant fraction was transferred to a clean tube. The supernatant fraction was
centrifuged again for 3 minutes to remove any residual precipitate. Aliquots (200 pi)
were injected into a tri-iodide solution, which consist of 400mg of potassium iodide, 260
mg of iodine, 8ml of Millipore water, and 28 ml of 100% acetic acid. This solution
reduced nitrite, iron-nitrosylheme, and S-nitrosothiol into gaseous NO, which was then
measured with an ozone-based chemiluminescence detector (Model 280i Sievers, NO
analyzer, Boulder, CO). Although this method measures nitrite in the blood, the ultimate
source of the nitrite was from nitric oxide.
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Procedures
Upon arrival, subjects signed an informed consent document and were asked to
remain seated and relaxed for a total of 10 minutes so that they could acclimatize to the
environment (220-24° C). Once acclimatized, subjects had their first blood sample taken
and then skin blood flow was measured. Subjects then sat in front of the vibration
platform with their dominant forearm and hand placed palm down on the platform with
the elbow bent at about 110°. Five minutes of 50 Hz high frequency vibration was then
applied to the forearm. Immediately after, another skin blood flow measurement and
then blood sample were taken. The subjects then remained seated in a similar position
for 5 minutes of recovery, after which one more blood sample and then skin blood flow
measurement were taken.

Analysis
NO concentrations were measured as venous nitrite concentration (see Methods)
in collected specimens of venous blood and expressed in units of pmoles/ltr. Blood flow
in the skin was determined by laser Doppler (see Methods) and expressed in relative units
of flux rather than absolute units of Itr/sec. The rate of NO production is equal to the
product of the blood nitrite concentration and rate of blood flow and is expressed in
relative units of (pmole/ltr)»(flux) rather than in units of pmole/sec. Thus, to determine
the rate of NO production, a modified version of Pick’s Principle was used (Boron and
Boulpaep, 2003; see equation below):
R= C • F
where, C= nitrite concentration of blood (moles/ltr)
F = relative blood flow (Itr/sec) or = flux
R = rate of production (moles/sec) or (moles/ltr)(flux)
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Results
No significant difference was found between group mean baseline skin blood
flows. Skin blood flow significantly increased by 461% in the healthy adults and by
223% in the adults with diabetes (p=0.0001). (Table 3.2, Figure 3.1.) Skin blood flows
remained elevated at 250% in the healthy adults and at 149% in the adults with diabetes.
There was a significant difference (p=0.003) between mean skin blood flow in the two
groups, immediately after vibration and after 5 minutes of recovery. No significant
difference was found between groups in NO levels. NO levels dropped after vibration in
the healthy adults and then increased slightly after 5 minutes of recovery. In the adults
with diabetes, NO levels increased after vibration and then increased even higher after 5
minutes of recovery (Table 3.3, Figure 3.2). NO production, expressed as NO (pmole/ltr)
•(flux), increased significantly by 374% in the healthy adults and 236% in the adults with
diabetes (p=0.0001). After 5 minutes of recovery, NO (pmole/ltr) -(flux) remained
significantly high at 258% for the healthy adults and 177% in the adults with diabetes
(p=0.01)(Table 3.4, Figure 3.3).
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Discussion
Previous studies conducted in our laboratory determined that NO resulted in the
majority of skin blood flow increases due to vibration in young healthy adults. The intent
of this research was to determine if NO and skin blood flow increases could also be found
in healthy older adults and adults with diabetes. In both the healthy older adults and the
adults with diabetes, significant increases were found in NO production, expressed in this
paper as NO (pmole/ltr) ‘(flux), after 5 minutes of 50 Hz vibration and after 5 minutes of
recovery. Although mean NO production for the group with diabetes was lower than the
healthy older adults, it was not significantly different.
Multiple theories suggest that with diabetes and to a lesser extent with aging, the
NO pathway becomes dysfunctional. Literature suggests that the problem is, 1)
decreased endothelial NO production, 2) Inability of NO to reach the smooth muscle or,
3) Inability of smooth muscle to respond to NO (Traub & Van Bibber, 1995). Decreased
NO production is suggested to be from low L-arginine levels or the uncoupling of eNOS
(Pieper 1998; Cai & Harrison 2000; Forstermann and Munzel 2006; Thum et ai, 2007).
Our study does not support the idea that there is a decrease in NO production. In both
groups, NO production increased in response to the vibration. Even before correction for
flow, the group with diabetes showed increases in NO levels. Obviously, in both groups
NO was being produced. In the group with diabetes, however, there was a significantly
lower skin blood flow response to vibration. Therefore, the main problem must lie
outside of the endothelial cells. Research also suggests NO cannot reach the smooth
muscle due to advanced glycosylation end products building up and inactivating NO
(Bucala et ai, 1991). This does not appear to be the case, since NO levels before
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correction were not only present, but increased over time. It has also been suggested that
glucose mediated intimal thickening prevents NO from traveling to the smooth muscle
(Roy et ai, 1990; Traub & Van Bibber, 1995). This may be part of the reason for the
lower skin blood flow response in the diabetic group. There still was a significant
increase in skin blood flow and NO production, which suggests that the NO was getting
to the smooth muscle most if not all of the time. This finding points to the likelihood that
the smooth muscle is the limiting factor. Studies have found decreased guanylate cyclase
activity (cGMP) (Weisbrod et al, 1993) and inhibited Na/K ATPase activity in those
with diabetes (Traub & Van Bibber, 1995). It is our assumption that these two
mechanisms are the main cause of the inefficiency of NO to vasodilate the smooth
muscle.
These effects may worsen with the advancement of the disease process and
eventually lead to decreased bioavailability of NO as well. One of the reasons we still
saw the production of NO in the diabetic group might have been due to the overall good
glucose control in our diabetic sample. The mean A1C level was 6.5%. According to the
American Association of Clinical Endocrinologists < 6.5% is considered good glucose
control. Most research agrees that poor glucose control is responsible for the impaired
vascular response. It is important, however, to note that the skin blood flow response was
significantly lower than that of the healthy older adults, even though glucose levels were
well managed. Future research should examine those with moderate and poor glucose
control.
Another area which should be examined closer is the changes in response to
vibration that occur with age. In previous studies in our lab, healthy young adults had a
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mean NO production of 49.4 ± 36.4 and a mean skin blood flow of 327 ±229.3 after
vibration. In the current study, healthy older adults had a mean NO production of 41.2 ±
21.5 and a mean skin blood flow of 280.8 ± 172.2, and the older adults with diabetes had
a mean NO production of 28.1 ± 12.7 and a mean skin blood flow of 140.4 ± 70.9. So, it
appears that there is a decline in both measurements with age, and more so with the
addition of diabetes. Even though future studies may find vibration may not work as well
with age, vibration still promotes a significant increase in skin blood flow and NO.
As mentioned earlier, with age and diabetes comes an increased risk for
cardiovascular disease. Any method that can promote NO production may have the
ability to halt, slow, or reverse this process. With diabetes, wound healing is also
compromised (Petrofsky & Lawson 2007, Blakytny & Jude, 2006). The ability to
increase blood flow and NO to the injured area might speed or aid in the healing process.
Our study has shown that acute exposure to 50 Hz vibration for 5 minutes can increase
NO levels and skin blood flow in healthy older adults and people with diabetes.
Additionally, these factors remain significantly elevated for at least 5 minutes. If
vibration is to be used as a treatment, future studies should be done to determine if
repeated exposure provides the same results.
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Tables

Table 3.1. Subject characteristics
Group

Age (yrs)

Weight (kg)

Height (cm)

BMI

N

Older Adult

55.0 ±7.7

87.0 ±12.7

171.7 ±4.6

29.3 ± 3.3

10

Diabetic

56.9 ±7.5

91.4 ± 16.2

171.5± 15.0

29.9 ± 2.6

10

4
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Table 3.2. Skin blood flow in healthy adults and adults with diabetes. Means and
SD for skin blood flow in healthy adults and diabetic adults at baseline, immediately after
vibration, and after 5 minutes of recovery.
Skin Blood Flow, (Flux)
Group

Baseline

Vibration

Recovery

Healthy Adult

60.9 ±32.1

280.8 ± 172.2

152.3 ±63.8

Diabetic

62.9 ±21.9

140.4 ±70.9

93.7 ±49.4
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Table 3.3. NO levels in healthy adults and adults with diabetes. Means and SD for Nitric
Oxide in healthy adults and diabetic adults at baseline, immediately after vibration, and
after 5 minutes of recovery.
NO Levels (|aM)
Group

Baseline

Vibration

Recovery

Healthy Adult

0.17 ±0.06

0.16 ±0.09

0.18 ± 0.10

Diabetic

0.18 ±0.09

0.22 ±0.10

0.23 ±0.14
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Table 3.4. NO production in healthy adults and adults with diabetes. Means and SD for
NO (pmole/ltr) '(flux) (product of NO and skin blood flows) in healthy adults and
diabetic adults at baseline, immediately after vibration, and after 5 minutes of recovery.
NO Production, (pmole/ltr) '(flux)
Group

Baseline

Vibration

Recovery

Healthy Adult

11.1 ± 8.3

41.6 ± 21.5

28.6 ±21.7

Diabetic

11.9 ±7.61

28.1 ± 12.7

21.1 ± 14.5
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Figures

Skin blood flow in healthy adults and adults with diabetes
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Figure 3.1. Mean skin blood flow for Healthy Adult (0) and Diabetic Adult (□) groups
at baseline, after 5 minutes of 50 Hz vibration, and after 5 minutes of recovery.
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NO concentrations in healthy adults and adults with diabetes
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Figure 3.2. Mean NO concentrations for Healthy Adult (0) and Diabetic Adult (□)
groups at baseline, after 5 minutes of 50 Hz vibration, and after 5 minutes of recovery.
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NO production in healthy adults and adults with diabetes

Figure 3.3. Mean NO production for Healthy Adult (0) and Diabetic Adult (□) groups at
baseline, after 5 minutes of 50 Hz vibration and after 5 minutes of recovery.
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CHAPTER 5
CONCLUSION

Both 30 Hz and 50 Hz passive vibration are capable of inducing increases in skin
blood flow to the forearm. Significant increases can be obtained within four minutes and
peak skin blood flows by the fifth minute of vibration. Skin blood flow can remain
elevated even after vibration has ceased. 50 Hz appears to be superior to 30 Hz, due to its
ability to increase skin blood flow more rapidly than 30 Hz. Additionally, 50 Hz
vibration provides elevated skin blood flows for 15 minutes after vibration ceases
whereas, 30 Hz vibration produces vasoconstriction after 9 minutes of recovery.
These increases in skin blood flow appear to be regulated by nitric oxide. Skin
blood flow increases and decreases in accordance with NO production. After only 5
minutes of vibration, skin blood flow and NO production significantly increased and after
5 minutes of recovery, they both significantly decreased. Additionally, when NO
production is blocked with the iontophoresis of L-NAME, the vibration-induced
increases in skin blood flow can be blocked by 40%. This points to the fact that NO, if
not the only mechanism, plays a large role in vibration induced increases in skin blood
flow.
NO also appears to regulate the vibration-induced increases in skin blood flow in
older adults and adults with type II diabetes. In both populations, NO production
increases significantly with 5 minutes of 50 Hz vibration. Significant increases in skin
blood flow occur in both populations; however, the increases in the adults with type II
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diabetes are significantly less than the healthy older adults. Although skin blood flow
can still be increased in both populations, there appears to be a problem with the diffusion
of NO to the smooth muscle or a problem within the smooth muscle itself.
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